Lauren Wiatrowski
Medical · Buffalo, NYNPI 1407323546
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 678 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Amgen at 26.6% of the total. Among medical clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 678 payments — averaging $26.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$5K
- Johnson & Johnson$2K
- UCB, Inc.$2K
- AbbVie$2K
- Pfizer$2K
- Mallinckrodt Hospital Products Inc.$1K
- plus $5K from 21 others
What the payments were for
- Food & beverage$17,56098%
- Education$3522%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 121 | $4,761 |
| Johnson & Johnson | 105 | $1,862 |
| UCB, Inc. | 104 | $1,816 |
| AbbVie | 60 | $1,530 |
| Pfizer | 101 | $1,512 |
| Mallinckrodt Hospital Products Inc. | 28 | $1,438 |
| Sanofi | 20 | $1,357 |
| AstraZeneca(2 entities) | 29 | $853 |
| Aurinia Pharma U.S., Inc. | 14 | $488 |
| Sandoz | 22 | $417 |
| GSK | 12 | $232 |
| Boehringer Ingelheim | 10 | $207 |
| Lilly USA, LLC | 11 | $194 |
| ANI Pharmaceuticals, Inc. | 8 | $190 |
| Organon | 8 | $169 |
| Sanofi-aventis U.S. LLC | 2 | $159 |
| Novartis | 1 | $140 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Kyowa Kirin, Inc. | 5 | $120 |
| Actelion Pharmaceuticals US, Inc. | 4 | $90 |
| Genentech USA, Inc. | 3 | $82 |
| Scilex Pharmaceuticals Inc. | 4 | $65 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $29 |
| Dermavant Sciences, Inc. | 1 | $22 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $21 |
| Celltrion USA Inc. | 1 | $20 |
| Bio Products Laboratory USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,912 in reported general payments places this provider in the 95th percentile of 2,395 medical providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 22 | $213,459 |
| KevzaraSarilumab | 24 | $109,498 |
| OtezlaApremilast | 16 | $77,525 |
| XeljanzTofacitinib Citrate | 12 | $70,880 |
| Simlandi(Cf) AutoinjectorAdalimumab-Ryvk | 17 | $24,420 |
| Hydroxychloroquine Sulfate | 238 | $13,272 |
| MethotrexateMethotrexate Sodium | 347 | $11,521 |
| Azathioprine | 115 | $3,560 |
| Leflunomide | 42 | $2,910 |
| Colchicine | 36 | $1,822 |
| Sulfasalazine DrSulfasalazine | 48 | $1,560 |
| Prednisone | 244 | $1,538 |
| Sulfasalazine | 15 | $818 |
| Mycophenolate Mofetil | 20 | $695 |
| Folic Acid | 75 | $662 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| SanofiKevzara | $1,357 | $109,49824 claims |
| AmgenOtezla | $4,761 | $77,52516 claims |
| PfizerXeljanz | $1,512 | $70,88012 claims |
| Scilex Pharmaceuticals Inc.Colchicine | $65 | $1,82236 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,395 medical providers in New York.
Other medical in Buffalo
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
- Ilse StraussSmithtown$87K
- Helen AdamsNew York$87K
- Hailey BrickmanNew York$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.